Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT
Clinical trial NCT07498517 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07498517
- Sponsor
- OHSU Knight Cancer Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-28
- Primary completion
- 2029-02-02
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.